Explore how a pharmaceutical microbiology program can confidently adopt AI-enabled automated plate reading systems while staying compliant in GxP environments. It introduces a practical, risk-based approach to validation that shifts the focus from “black box” concerns to system performance, intended use, and data integrity. Covering the full lifecycle from selection and qualification to ongoing monitoring and change management, this whitepaper provides clear guidance on meeting regulatory expectations while unlocking the efficiency and consistency benefits of automation in pharmaceutical manufacturing. A must-read for organizations looking to modernize microbiology operations without compromising compliance.

Whitepaper: Clever Culture Systems

Date: April 2026

Authors: Julie Winson and Steven Giglio, PhD

‍